At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

A phase 3 PROTEUS substudy published in European Urology reports that perioperative apalutamide plus hormone therapy around ...

Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...

Approximately 14 percent of men will be diagnosed with prostate cancer at some point in their lifetimes, according to the National Institutes of Health. Radiation therapy traditionally has been a ...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ADT compared with immediate ...

What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...

The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...

"Robotic Prostate Cancer Surgery Has a 3.3% Transfusion Rate; Readmission and Reoperation Rates Also Low" ...

A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...

The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...